July 2026 in “Mendeley Data” Higher doses of oral minoxidil can help hair growth but may cause side effects.
July 2026 in “Mendeley Data” Higher doses of oral minoxidil can help hair growth but may cause side effects.
November 2025 in “Cancer Reports” In this study, women who underwent chemotherapy for breast cancer in Islamabad, Pakistan, reported significant physical and psychological challenges, as well as economic strain; the authors concluded that government support and improved pre-treatment counseling could help mitigate these issues.
April 2025 in “Archives of Dermatological Research” This study found that in patients with androgenetic alopecia, microneedling therapy led to significantly higher treatment adherence compared to medication, with improved adherence linked to factors like age, education, income, reduced side effects, and enhanced treatment efficacy.
August 2024 in “Journal of Aesthetic Nursing” Francesca Ramadan provides an overview of various non-surgical hair restoration and rejuvenation treatments available in aesthetic clinics, highlighting advancements beyond currently limited drug options due to side effects, as reported in this review.
In this study, both 5% and 10% topical minoxidil showed similar overall efficacy in treating male-pattern hair loss, though the 10% concentration resulted in greater improvement in frontal hair count but also more side effects.
April 2024 in “Tạp chí Y học Thảm hoạ và Bỏng” This review discusses various treatment options for androgenetic alopecia, considering factors such as effectiveness, side effects, and cost, but reports no new clinical results.
This study found that treatments with adipose-derived stem cell secretome and minoxidil significantly improved hair growth in androgenetic alopecia, with the combination therapy showing the greatest improvement over 12 weeks.
This study found that 23.2% of surveyed dermatologists in Saudi Arabia prescribe Tofacitinib for alopecia areata, with 72.4% reporting its effectiveness, while 47.7% cited unavailability as the main reason for not prescribing.
May 2023 in “Hair transplant forum international” No specific results are reported in this abstract, but it mentions that minoxidil is mainly used for hypertension that does not respond to other treatments due to side effects like tachycardia, fluid retention, and hypertrichosis.
February 2023 in “Deleted Journal” This study aimed to create and assess an herbal shampoo that prioritizes safety, efficacy, and quality, as an alternative to conventional shampoos that can cause side effects such as hair loss and scalp irritation.
April 2022 in “Medicinus” This article discusses the challenges of treating androgenetic alopecia due to limited approved medications, potential side effects, and unmet expectations and reports no new clinical results.
January 2021 in “Journal of clinical & experimental dermatology research” This study found that a new propylene glycol-free 5% minoxidil lotion demonstrated good clinical efficacy and very good cosmetic acceptability and tolerability after six months of use in patients with androgenetic alopecia, showing results comparable to traditional formulations containing propylene glycol.
This study suggests that oral JAK inhibitors can be an effective treatment option for approximately half of patients with moderate to severe alopecia areata, despite variable responses and potential adverse effects.
December 2006 in “Belarusian State Pedagogical University repository (Belarusian State Pedagogical University)” This article discusses the controversy surrounding artificial hair fibers in India, reporting no new results, and provides guidelines for dermatologists on their usage.
March 2005 in “Journal of The American Academy of Dermatology” Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.
September 2015 in “Korean Journal of Clinical Pharmacy” In this study, topical minoxidil 7% with dutasteride 0.5 mg showed higher efficacy but more adverse effects compared to minoxidil 7% with finasteride 1 mg for treating androgenetic alopecia.
September 2022 in “Journal of The American Academy of Dermatology” This study explored patient attitudes, perceptions, and barriers to using topical minoxidil for hair loss, with most respondents being female and many African American.
60 citations
,
September 2004 in “Pediatric Dermatology” In this study, a 10-year-old girl developed vitiligo and psoriasis during IFN-alfa treatment for chronic hepatitis B, with neither condition improving after stopping the therapy.
44 citations
,
July 2013 in “Journal of the American Academy of Dermatology” This review discusses various genetic and acquired conditions associated with poliosis circumscripta and reports no new clinical results.
14 citations
,
January 2006 in “Skinmed” A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.
January 2026 in “Revista Colombiana de Ciencias Químico Farmacéuticas” This review discusses the efficacy of Minoxidil and finasteride for treating androgenetic alopecia and suggests that combined therapy may offer superior results and improved patient adherence despite potential side effects.
This article reviews different generations of synthetic retinoids for dermatological use, discussing their efficacy and significant side effects, but reports no new clinical results.
May 1987 in “Inpharma (Balgowlah)” Topical minoxidil may slow hair loss but often doesn't lead to satisfactory hair regrowth and requires ongoing treatment.
February 1976 in “PubMed” This article discusses the effectiveness and indications of sex hormone therapy for various skin disorders and emphasizes the importance of avoiding androgen-effective contraceptives, but reports no new clinical results.
2152 citations
,
November 2013 in “Urologia Internationalis” This study reviews the significant prevalence of organic etiologies, especially vascular causes, in erectile dysfunction among men under 40 and emphasizes thorough evaluation and consideration of treatment options like exercise and PDE-5 inhibitors.
294 citations
,
February 1994 in “PubMed” This review highlights valproic acid's efficacy and tolerability as a first-line treatment for various seizure types in both adults and children, emphasizing its minimal neurological adverse effects compared to other antiepileptic drugs.
235 citations
,
September 2004 in “The Journal of urology/The journal of urology” This review discusses the role of dihydrotestosterone in benign prostatic hyperplasia and reports no new results; the authors highlight 5alpha-reductase inhibitors as a well-established treatment option.
187 citations
,
June 1999 in “Journal of The American Academy of Dermatology” This study reported that finasteride 1 mg/day significantly increased hair growth and slowed hair loss in men with frontal scalp hair thinning over one year, and these benefits continued or improved in the second year.
146 citations
,
July 2003 in “Journal of the American Academy of Dermatology” In this study, clobetasol propionate 0.05% ointment was found to induce hair regrowth in 28.5% of patients with severe alopecia areata under occlusive conditions, though long-term benefit was limited to 17.8%.